IDUN TECHNOLOGIES AG

Their core work

IDUN Technologies is a Zurich-based deep-tech SME specializing in wearable biomedical electrode technology. Their core product is dry, preparation-free electrodes — sensors that capture biosignals (EEG, ECG, EMG) without the gel or skin preparation required by clinical-grade equipment. Their work targets the gap between hospital-grade accuracy and everyday wearability, making continuous biosignal monitoring practical for real-world use. In EU projects they contribute as both a technology developer and a commercial SME driving biomedical hardware from research toward market-ready devices.

What they specialise in

How they've shifted over time

Both H2020 projects began in 2019, so there is no meaningful longitudinal shift in focus to analyze — the dataset covers a single entry point into EU-funded research. Early keywords center on stretchable multi-pad biomedical electrodes (WEARPLEX), while the later project record (Dryode) carries no keyword metadata, making trend inference unreliable. Based on project structure alone, IDUN entered EU funding with a clear and narrow thesis — dry wearable electrodes — and pursued it through two complementary instruments simultaneously rather than evolving across time.

IDUN appears to be moving from research participation toward market-entry, as evidenced by their SME Instrument Phase 1 coordinator role — a signal of a company building a commercial case around its core electrode IP.

How they like to work

IDUN operates both as a consortium participant in larger RIA projects and as a sole-lead coordinator in SME-focused grants, showing flexibility across project formats. With 10 unique partners across 8 countries from just two projects, their network is broad relative to their project count — suggesting active relationship building rather than deep repeat collaboration. They are most likely to enter consortia as a specialist hardware contributor, providing proprietary electrode technology rather than leading large multi-partner research agendas.

IDUN has built connections with 10 distinct organizations across 8 European countries through only two projects, indicating a deliberately diversified partner base. No geographic concentration is evident from available data, consistent with a Swiss SME seeking pan-European market validation.

What sets them apart

IDUN occupies a narrow but commercially valuable niche: they make the electrode, not the device — a hardware component that every wearable biosignal system needs but few SMEs specialize in. Their focus on dry, preparation-free designs directly addresses the main barrier to clinical-to-consumer transition in wearable health tech. For consortium builders working on EEG, ECG, or EMG-based applications, IDUN offers verified IP and SME-scale agility that academic labs and large medtech firms cannot easily replicate.

Highlights from their portfolio

• WEARPLEX
  The largest investment in IDUN's H2020 portfolio (EUR 338,125 RIA, 2019–2022), this project placed them inside a multi-country research consortium developing stretchable multiplexed electrode arrays — their most technically ambitious EU engagement.
• Dryode
  As sole coordinator of this SME Instrument Phase 1 grant, IDUN used EU funding to validate the commercial case for their preparation-free electrode concept — a strong signal of market-readiness intent.